| Financial Year |
March 31 2023 |
| Monetary Funds |
896,234,775.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
17,442,141.83 |
| Accounts Receivable |
3,434,208,457.04 |
| Advances to Suppliers |
372,815,150.09 |
| Other Receivables |
135,543,934.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,387,661,302.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,286,910.26 |
| Total Current Assets |
6,686,541,038.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
672,433,198.62 |
| Investment Properties |
-- |
| Fixed Assetes |
816,336,441.42 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
403,580,431.53 |
| R&D expenses |
107,805,746.02 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
187,791.27 |
| Deferred Income Tax Assets |
101,493,594.94 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,473,243,548.80 |
| Total Assets |
9,159,784,587.49 |
| Short-Term Loans |
475,416,668.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
147,861,941.49 |
| Accounts Payable |
3,474,164,447.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
54,616,447.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
180,539,111.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
26,316,234.71 |
| Other Current Liabilities |
63,388,438.47 |
| Sub-Total of Current Liabilities |
5,122,425,011.66 |
| Long-term Loans |
335,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,861,625.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
382,772,593.71 |
| Total Liabilities |
5,505,197,605.37 |
| Paid-In Capital(Or Share Stock) |
706,111,684.00 |
| Capital Surplus |
1,366,784,927.77 |
| Surplus Reserve |
221,106,681.30 |
| LESS:Treasury Stock |
54,181,014.00 |
| Undistributed Profits |
463,638,177.11 |
| Minority Stockholder's Interest |
897,780,154.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,756,806,827.84 |
| Owner's Equity（Stockholder's Equity） |
3,654,586,982.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,159,784,587.49 |
